Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$56.4M |
| 2 |
Chemed
CHE
|
+$53.8M |
| 3 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$53.1M |
| 4 |
Petrobras
PBR
|
+$52.7M |
| 5 |
FIEG
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMER
FIRSTMERIT CORP
FMER
|
+$58.7M |
| 2 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$38.2M |
| 3 |
PL
PROTECTIVE LIFE CORP
PL
|
+$37.8M |
| 4 |
Sally Beauty Holdings
SBH
|
+$36.2M |
| 5 |
TSMC
TSM
|
+$35.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.26% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.41% |
| 4 | Industrials | 7.4% |
| 5 | Consumer Discretionary | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Emerson Electric
EMR
$83.9B
| $521K | ﹤0.01% |
8,317
+735
| +10% | +$47.7K |
|
377
Vertex Pharmaceuticals
VRTX
$121B
| $516K | ﹤0.01% |
4,593
-2,160
| -32% | -$206K |
|
378
Under Armour
UAA
$2.84B
| $496K | ﹤0.01% |
14,456
-8,133
| -36% | -$269K |
|
379
Norfolk Southern
NSC
$75.4B
| $485K | ﹤0.01% |
4,350
+100
| +2% | +$10.6K |
|
380
Align Technology
ALGN
$12.1B
| $477K | ﹤0.01% |
9,228
-11,890
| -56% | -$648K |
|
381
Abbott
ABT
$183B
| $468K | ﹤0.01% |
11,261
-6,766
| -38% | -$286K |
|
|
WBA
382
DELISTED
Walgreens Boots Alliance
WBA
| $468K | ﹤0.01% |
7,901
+3,147
| +66% | +$206K |
|
383
HP
HPQ
$24.9B
| $466K | ﹤0.01% |
28,899
-2,513
| -8% | -$40.8K |
|
384
ING
ING
$99.8B
| $463K | ﹤0.01% |
32,662
| – | – |
|
385
Lowe's Companies
LOW
$117B
| $463K | ﹤0.01% |
8,743
-220
| -2% | -$11.1K |
|
|
ETP
386
DELISTED
Energy Transfer Partners L.p.
ETP
| $461K | ﹤0.01% |
7,206
-1,210
| -14% | -$70K |
|
|
EMC
387
DELISTED
EMC CORPORATION
EMC
| $459K | ﹤0.01% |
15,698
+35
| +0.2% | +$1.01K |
|
|
CS
388
DELISTED
Credit Suisse Group
CS
| $417K | ﹤0.01% |
+15,094
| New | +$421K |
|
|
BNY
389
Bank of New York Mellon
BNY
$106B
| $412K | ﹤0.01% |
10,637
| – | – |
|
390
Vodafone
VOD
$36.3B
| $411K | ﹤0.01% |
12,506
-1,999
| -14% | -$66.7K |
|
391
Eastman Chemical
EMN
$8B
| $410K | ﹤0.01% |
5,069
+74
| +1% | +$6.18K |
|
392
PNC Financial Services
PNC
$99.7B
| $405K | ﹤0.01% |
4,728
+472
| +11% | +$40.1K |
|
393
Enterprise Products Partners
EPD
$82.3B
| $404K | ﹤0.01% |
10,029
-2,121
| -17% | -$83.2K |
|
394
British American Tobacco
BTI
$131B
| $403K | ﹤0.01% |
7,128
-3,860
| -35% | -$228K |
|
|
XEC
395
DELISTED
CIMAREX ENERGY CO
XEC
| $397K | ﹤0.01% |
3,138
+138
| +5% | +$19.1K |
|
396
PLDT
PHI
$4.25B
| $393K | ﹤0.01% |
5,696
| – | – |
|
397
3M
MMM
$90.9B
| $389K | ﹤0.01% |
3,285
-313
| -9% | -$37.6K |
|
398
Medtronic
MDT
$109B
| $382K | ﹤0.01% |
6,165
+150
| +2% | +$9.54K |
|
|
PCYC
399
DELISTED
PHARMACYCLICS INC
PCYC
| $381K | ﹤0.01% |
3,244
-1,870
| -37% | -$213K |
|
400
Mondelez International
MDLZ
$79.5B
| $377K | ﹤0.01% |
10,993
+1,992
| +22% | +$72.6K |
|
Similar funds
Ken Fisher's Q3 2014 Portfolio in Review
As of Q3 2014, Ken Fisher held 645 positions worth $46.9B, down 1.4% from $47.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q3 2014 filing shows 47 new, 202 increased, 264 reduced and 61 closed positions. Its largest new stake was Chemed: 530,910 shares worth $54.6M. The largest sale was FIRSTMERIT CORP, an estimated $58.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Ken Fisher's largest Q3 2014 buy was Chemed: 530,910 shares worth $54.6M.
- Ken Fisher added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2014, an estimated $56.4M increase.
- Ken Fisher's biggest Q3 2014 reduction was FIRSTMERIT CORP, cutting an estimated $58.7M.
- Ken Fisher fully exited PROTECTIVE LIFE CORP in Q3 2014, selling an estimated $37.8M.
- Ken Fisher's ten largest holdings make up 22% of its $46.9B portfolio in Q3 2014.
- Ken Fisher opened 47 new positions and closed 61 in Q3 2014.
- Ken Fisher's portfolio value fell 1.4% quarter-over-quarter to $46.9B.
Based on Fisher Asset Management's 13F filing for Q3 2014, filed 20 Oct 2014.